Clinical Trials Browser

INDUSTRY × Vorinostat × Tumor-Agnostic × Clear all

NCT00127127 2022-09-13

MK-0683-029

Phase 1 Completed

18 enrolled 24 charts

Neoplasms

NCT00750178 2017-04-07

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK0683 in Patients With Advanced Cancer (0683-008)

Phase 1 Completed

Neoplasms